Background
What Is BPC-157?
BPC-157, short for Body Protection Compound-157, is a synthetic peptide consisting of 15 amino acids. It is derived from a protective protein found naturally in human gastric juice. Researchers first identified the parent protein in the stomach lining, where it plays a role in maintaining the integrity of the gastrointestinal tract. The synthetic pentadecapeptide BPC-157 was subsequently isolated and studied for its remarkably broad range of protective and regenerative properties in preclinical models.
The compound has been the subject of extensive preclinical research across multiple therapeutic domains. Studies in animal models have investigated BPC-157 in the context of tendon and ligament healing, where it has been shown to accelerate the repair of transected Achilles tendons and medial collateral ligaments. Researchers have also explored its effects on gut barrier repair, demonstrating protective effects against NSAID-induced gastric lesions, inflammatory bowel disease models, and intestinal anastomosis healing. Additional areas of investigation include muscle tissue regeneration following crush injuries, bone fracture healing, neuroprotection in models of traumatic brain injury, and wound healing in skin and corneal tissue.
Within the health optimization community, BPC-157 has become one of the most widely discussed and frequently used peptides. Its popularity stems from the breadth of its reported benefits: users track BPC-157 protocols for joint and tendon recovery after athletic injuries, for gut healing following courses of antibiotics or NSAIDs, for accelerating recovery from surgical procedures, and for general tissue repair and anti-inflammatory support. Many users run BPC-157 alongside TB-500 in what has become known as the Wolverine Stack, a combination believed to provide synergistic healing effects.
Precise tracking matters with BPC-157 because the peptide is typically used in structured cycles rather than continuously. Most protocols involve a loading phase at higher amounts for the first one to two weeks, followed by a maintenance phase at reduced amounts for an additional two to four weeks. After completing a cycle, users generally observe a rest period before beginning another round. The distinction between loading and maintenance phases, the importance of consistent daily timing, the need to rotate application sites, and the requirement to track reconstitution concentrations all make BPC-157 an ideal candidate for dedicated protocol tracking software. Without a structured tracking tool, users risk inconsistent administration, forgotten applications, and poor documentation of what is and is not working in their recovery protocol.